{"id":"https://openalex.org/W84051292","doi":null,"title":"[Timeline from discovery of 5-FU to development of an oral anticancer agent S-1 and its drug concept].","display_name":"[Timeline from discovery of 5-FU to development of an oral anticancer agent S-1 and its drug concept].","alternate_titles":[],"publication_year":2006,"publication_date":"2006-06-01","ids":{"openalex":"https://openalex.org/W84051292","mag":"84051292","pmid":"https://pubmed.ncbi.nlm.nih.gov/16897967"},"language":"ja","primary_location":{"id":"pmid:16897967","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16897967","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gan to kagaku ryoho. Cancer & chemotherapy","raw_type":"English Abstract"},"parent_works":[],"lineage":["https://openalex.org/W84051292"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113793342","display_name":"Tetsuhiko Shirasaka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I64189623","display_name":"Kitasato University","ror":"https://ror.org/00f2txz25","country_code":"JP","type":"education","lineage":["https://openalex.org/I64189623"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tetsuhiko Shirasaka","raw_affiliation_strings":["Kitasato Institute for Life Science, Kitasato University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kitasato Institute for Life Science, Kitasato University","institution_ids":["https://openalex.org/I64189623"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112141513","display_name":"T Taguchi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tetsuo Taguchi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.4024,"has_fulltext":false,"cited_by_count":20,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.50317537,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"33 Suppl 1","issue":null,"first_page":"4","last_page":"18"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.4004000127315521,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.4004000127315521,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.3400999903678894,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.04470000043511391,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.9670000076293945},{"id":"https://openalex.org/keywords/s-1","display_name":"S-1","score":0.9300000071525574},{"id":"https://openalex.org/keywords/oral-anticancer-drugs","display_name":"oral anticancer drugs","score":0.8259999752044678},{"id":"https://openalex.org/keywords/prodrugs","display_name":"prodrugs","score":0.6710000038146973},{"id":"https://openalex.org/keywords/uft","display_name":"UFT","score":0.859000027179718},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.42100000381469727},{"id":"https://openalex.org/keywords/continuous-intravenous-infusion","display_name":"continuous intravenous infusion","score":0.7739999890327454},{"id":"https://openalex.org/keywords/time-dependent-pharmacokinetics","display_name":"time-dependent pharmacokinetics","score":0.5049999952316284},{"id":"https://openalex.org/keywords/history-of-drug-development","display_name":"drug development history","score":0.5210000276565552},{"id":"https://openalex.org/keywords/quality-of-life-in-cancer-patients","display_name":"quality of life in cancer patients","score":0.753000020980835},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.6000000238418579}],"concepts":[{"id":"https://openalex.org/C2778397455","wikidata":"https://www.wikidata.org/wiki/Q50429865","display_name":"Antimetabolite","level":3,"score":0.6931330561637878},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6896755695343018},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5679557919502258},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5408726930618286},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5399641394615173},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.46646201610565186},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.38931185007095337},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2593415677547455}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D005641","descriptor_name":"Tegafur","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D005641","descriptor_name":"Tegafur","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005641","descriptor_name":"Tegafur","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010094","descriptor_name":"Oxonic Acid","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D010094","descriptor_name":"Oxonic Acid","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010094","descriptor_name":"Oxonic Acid","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011355","descriptor_name":"Prodrugs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":1,"locations":[{"id":"pmid:16897967","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16897967","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gan to kagaku ryoho. Cancer & chemotherapy","raw_type":"English Abstract"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2153244200","https://openalex.org/W93765599","https://openalex.org/W236285899","https://openalex.org/W2443536534","https://openalex.org/W2419532975","https://openalex.org/W2103846273","https://openalex.org/W2395837104","https://openalex.org/W2027678619","https://openalex.org/W2168388707"],"abstract_inverted_index":{"C.":[0],"Heidelberger":[1],"et":[2],"al":[3],"left":[4],"great":[5],"gifts":[6],"to":[7,55,66,78,88,112,166,246,273,317,351,428,472,498,533],"us.":[8],"Approximately":[9],"50":[10],"years":[11],"have":[12,174,212],"elapsed":[13],"since":[14],"their":[15],"discovery":[16,249],"of":[17,73,82,117,184,186,216,227,233,239,250,252,260,287,290,294,301,307,364,371,384,420,459,480,506,520,538],"5-FU":[18,40,119,137,167,241,291,308,318,348,365],"in":[19,105,230,257,262,270,319,339,341,381,405,446,541],"1957":[20],"before":[21,218],"eventually":[22],"elucidating":[23],"the":[24,28,89,106,115,158,187,194,231,247,268,271,276,302,320,343,369,382,385,435,447,457,466,478,504,517,534,542],"mechanisms":[25],"by":[26,95,192,224,298,310,366,397,439],"which":[27,141,152,181,221,313,342,356,378,406],"drug":[29,433],"exerts":[30],"its":[31,36,57,197,295,500],"pharmacological":[32,288,362],"actions":[33,289,363],"and":[34,49,101,126,129,145,173,189,199,259,292,304,309,327,360,373,392,412,434,461,482,491,509,526],"provokes":[35],"adverse":[37,127,146,154,200,296,330],"reactions.":[38,201],"Namely,":[39],"is":[41,53,92,102,222,314,334,354,375,379,400],"a":[42,70,177,213,225,240,323,328,417],"typical":[43],"antimetabolite":[44,136],"with":[45,121,282,322,522,527],"strong":[46],"time":[47,74],"dependency,":[48],"continuous":[50],"venous":[51],"infusion(CVI)":[52],"considered":[54],"be":[56,64],"optimal":[58],"regimen.":[59],"The":[60],"following":[61,344],"facts":[62],"may":[63],"mentioned":[65],"explain":[67],"why":[68],"such":[69],"long":[71,214],"period":[72],"has":[75,495],"been":[76,496],"spent":[77],"reach":[79],"this":[80],"level":[81],"research:":[83],"1)":[84],"5-FU,":[85,251],"when":[86],"administered":[87],"living":[90],"individual,":[91],"mostly":[93],"inactivated":[94],"hepatic":[96],"catabolic":[97],"enzymes":[98],"without":[99],"delay":[100],"then":[103],"excreted":[104],"urine,":[107],"thus":[108],"making":[109,299],"it":[110],"difficult":[111],"precisely":[113],"analyze":[114],"relationship":[116],"blood":[118,358],"concentrations":[120,359],"concentration":[122],"persistence,":[123],"anticancer":[124,133,143,237,280,337,403,524],"activity,":[125],"reactions;":[128],"2)":[130],"unlike":[131],"other":[132,523,528],"agents,":[134],"an":[135,205,335,401,430],"separately":[138],"generates":[139],"metabolites":[140,151],"show":[142,153],"activity":[144],"reactions,":[147,297],"as":[148,150],"well":[149],"reactions":[155],"only.":[156],"For":[157],"last":[159],"30":[160],"years,":[161],"we":[162,203,266],"paid":[163],"attention":[164],"especially":[165],"among":[168],"chemotherapeutic":[169],"agents":[170,525],"for":[171,176,347,456,477,503],"cancer":[172,508,539],"sought":[175],"long-lasting":[178],"therapeutic":[179,207,432,529],"modality":[180],"maintains":[182],"quality":[183],"life":[185],"patient":[188,190],"compliance":[191],"considering":[193],"balancing":[195],"between":[196],"effects":[198],"Consequently,":[202],"concretized":[204],"innovative":[206],"drug,":[208],"TS-1":[209],"(S-1).":[210],"We":[211,513],"history":[215],"research":[217],"developing":[219],"S-1,":[220,275],"represented":[223],"series":[226],"investigations":[228],"consisting":[229],"developments":[232],"Futrafur":[234],"(FT)--an":[235],"oral":[236,336,390,402],"agent":[238,281,338,404],"derivative":[242],"(prodrug)-in":[243],"1970":[244],"subsequent":[245],"above":[248],"UFT(FT:":[253],"Ura=1":[254],":":[255,422,424],"4)":[256],"1976,":[258],"S-1":[261,333,399,453,474,494,521],"1999.":[263],"To":[264],"date,":[265],"took":[267],"initiative":[269],"world":[272],"devise":[274],"first":[277],"self-rescuing":[278],"concept(SRC)-based":[279],"dual":[283],"actions,":[284],"i.e.,":[285],"enhancement":[286],"reduction":[293],"use":[300],"biochemical":[303],"enzymological":[305],"properties":[306],"combining":[311],"FT,":[312,410],"gradually":[315],"converted":[316],"body,":[321],"5-FU's":[324,329],"effect-enhancing":[325],"substance":[326],"reaction-reducing":[331],"substance.":[332],"capsule,":[340],"2":[345],"modulators":[346],"are":[349,414,514],"combined":[350,415,518],"FT:":[352],"one":[353],"CDHP(5-chloro-2,4-dihydroxypyridine)":[355],"increases":[357],"enhances":[361],"potently":[367],"inhibiting":[368],"degradation":[370],"5-FU;":[372],"another":[374],"Oxo(potassium":[376],"oxonate)":[377],"localized":[380],"mucosa":[383],"gastrointestinal":[386],"(GI)":[387],"tract":[388,511],"after":[389],"administration":[391],"reduces":[393],"GI":[394],"toxicities":[395],"provoked":[396],"5-FU.":[398],"these":[407],"3":[408],"components,":[409],"CDHP,":[411],"Oxo,":[413],"at":[416],"molar":[418],"ratio":[419],"1":[421],"0.4":[423],"1.":[425],"Our":[426],"conception":[427],"develop":[429],"SRC-based":[431],"preclinical":[436],"concepts":[437],"validated":[438],"numerous":[440],"basic":[441],"studies":[442],"were":[443],"demonstrated":[444],"also":[445],"clinical":[448],"trials.":[449],"In":[450],"January":[451],"1999,":[452],"was":[454,475],"approved":[455,476],"treatment":[458,479,505,540],"advanced":[460],"recurrent":[462],"gastric":[463],"cancers":[464],"through":[465],"priority":[467],"review":[468],"system.":[469],"From":[470],"2001":[471],"2005,":[473],"head":[481],"neck":[483],"cancer,":[484,486,490],"colon":[485],"non-small":[487],"cell":[488],"lung":[489],"breast":[492],"cancer.":[493,512],"applied":[497],"acquire":[499],"expanded":[501],"indications":[502],"pancreatic":[507],"biliary":[510],"confident":[515],"that":[516],"regimen":[519],"modalities":[530],"will":[531],"contribute":[532],"routine":[535],"medical":[536],"practice":[537],"future.":[543]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W84051292","counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
